Search for: "State v. Hatch"
Results 41 - 60
of 794
Sorted by Relevance
|
Sort by Date
19 Jan 2011, 8:47 am
” The second reason the Court should hear the case is to ensure the viability of the important antitrust case of Verizon v. [read post]
3 Nov 2010, 6:55 am
Mensing (09-993) and Actavis Elizabeth, LLC v. [read post]
16 Jul 2012, 10:17 am
In Eli Lilly & Co. v. [read post]
5 Sep 2018, 5:01 am
” In their press releases announcing the proposed legislation, Hatch and Cotton mentioned victims in their states whom Sessions also discussed. [read post]
10 Mar 2017, 1:22 pm
In Tabingo v. [read post]
5 Sep 2008, 8:28 am
USA, Inc. v. [read post]
16 Jul 2012, 4:31 pm
In United States v. [read post]
24 Jan 2012, 6:34 pm
Labs. v. [read post]
6 Apr 2009, 12:01 am
" PDL Biopharma, Inc. v. [read post]
22 Feb 2012, 5:49 pm
, Alcon Labs. v. [read post]
15 Feb 2013, 11:23 pm
In United States v. [read post]
29 Apr 2010, 6:37 pm
Enter Stengart v. [read post]
2 Sep 2009, 1:05 am
In Martin v. [read post]
15 Apr 2010, 5:20 am
In a Hatch-Waxman case involving Prandin®, one has three opinions. [read post]
17 Sep 2024, 2:42 pm
Hatch-Waxman established a framework for generic drug approvals in the United States. [read post]
2 Feb 2022, 1:59 pm
O’Hara is one of the oldest fishing companies in the United States. [read post]
9 Mar 2009, 2:07 pm
" United States v. [read post]
21 Feb 2007, 1:22 pm
In Marrama v. [read post]
3 Jul 2018, 7:13 am
Consequently, as is their right under Hatch-Waxman, UCB sued Appellants for patent infringement in the United States District Court for the District of Delaware. [read post]
4 Sep 2012, 7:04 am
We previously reported on developments in various United States Courts of Appeal decisions concerning reverse payments in Hatch-Waxman litigation settlements - that is, payments made by branded pharmaceutical patent holders to generic challengers to postpone market entry of the generic product. [read post]
